Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.
1M | 3M | 6M | 1Y p.a. | 2Y p.a. | 3Y p.a. | 5Y p.a. | 10Y p.a. | |
Total return | 7.6% | 16.58% | 20.7% | -0.99% | 8.91% | 8.16% | 3.5% | 7.84% |
Growth return | 7.6% | 16.58% | 20.7% | -0.99% | 8.91% | 8.02% | 0.24% | 0.35% |
Income return | 0% | 0% | 0% | 0% | 0% | 0.14% | 3.26% | 7.49% |
Type | Description |
Platinum International Healthcare | |
Platinum Asset Management | |
PLA0005AU | |
Not Rated | |
Unknown | |
5 Nov 2003 | |
$198.43 million (as at 31 Aug 2025) | |
$2.4533 (as at 16 Oct 2025) | |
$2.4459 (as at 16 Oct 2025) | |
Open |
Type | Description |
MER | 1.35% (as at 21 Aug 2025) |
Indirect Cost Ratio (ICR) | 1.36% (as at 30 Jun 2023) |
Performance fee (not included in ICR) | Not Available |
Minimum initial investment | $10,000.00 |
Minimum additional investments | |
Minimum redemption amount | $10,000.00 |
Holding (as at 31 Aug 2025) | Type | % of Portfolio |
Imricor Medical Systems Inc Chess Depository Interest | Equity | 4.41% |
Login now to view the complete list of holdings. |
The objective of the Platinum International Healthcare managed fund is To provide capital growth over the long?term by investing in health care companies from around the world, ranging from those companies engaged in early exploratory research through to those providing health care services directly to consumers (such as hospitals or health insurance).
The strategy of the Platinum International Healthcare managed fund is The Fund primarily invests in health care companies listed on securities markets around the world. It invests in companies engaged in many aspects of providing products and services to the health care industry such as biotechnology, pharmaceuticals, diagnostics, laboratory technologies, distribution, hospitals and nursing care, health insurance and the provision of information technology to such companies.
The APIR code of the Platinum International Healthcare managed fund is PLA0005AU.
Platinum International Healthcare’s total return last month was 7.6%. This was made up of a growth return of 7.6% and an income return of 0%. These returns were calculated as at 30 Sep 2025.
Platinum International Healthcare’s total return for the last three months was 16.58%. This was made up of a growth return of 16.58% and an income return of 0%%. These returns were calculated as at 30 Sep 2025.
Platinum International Healthcare’s one-year total return is -0.99%. This was made up of a growth return of -0.99% and an income return of 0%. These returns were calculated as at 30 Sep 2025.
Platinum International Healthcare’s one-year total return is 8.16%. This was made up of a growth return of 8.02% and an income return of 0.14%. These returns were calculated as at 30 Sep 2025.
The asset allocation of the Platinum International Healthcare managed fund is :
The Responsible Entity for the Platinum International Healthcare managed fund is Platinum Asset Management.
As at 31 Aug 2025, the size of the Platinum International Healthcare managed fund was $198.43 million.
The Platinum International Healthcare managed fund has an inception date of 5 Nov 2003.
The current entry price of the Platinum International Healthcare managed fund is $2.4533 per unit and the current exit price is $2.4459 per unit (as at 16 Oct 2025).
The current exit price of the Platinum International Healthcare managed fund is $2.4459 per unit and the current entry price is $2.4533 per unit (as at 16 Oct 2025).
The minimum initial investment amount for the Platinum International Healthcare managed fund is $10,000. Minimum additional investment is $0.
Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.